Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series
In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as the cause of a cluster of pneumonia cases in China, and the corresponding disease was designated as Coronavirus Disease 2019 (COVID-19), spreading quickly around the world resulting in a pandemic. COVID-19 i...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | article |
| Idioma: | English |
| Publicado em: |
Universidade de São Paulo
|
| Assuntos: | |
| Endereço do item: | https://repositorio.ufrn.br/handle/123456789/30974 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
| Resumo: | In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
as the cause of a cluster of pneumonia cases in China, and the corresponding disease was
designated as Coronavirus Disease 2019 (COVID-19), spreading quickly around the world
resulting in a pandemic. COVID-19 is associated with a set of coagulation abnormalities that
increase the risk of thromboembolic events, especially in patients with severe/critical disease.
We describe a series of five cases of mild COVID-19, treated in an outpatient clinic, which,
after an apparent clinical improvement, developed acute pulmonary embolism (APE) between
the third and the fourth week after the onset of symptoms, when they are mostly related to
acute illness disappearance. Thromboembolic events are also a potential complication of mild
COVID-19 and can manifest later in the disease course. This finding raises discussion about
the prevention of thromboembolic events in selected group of patients with mild COVID-19. |
|---|